Larry Anderson, Alfred Chung, Laahn Foster, Chakra Chaulagain, Erin Pettijohn, Andrew Cowan, Caitlin Costello, Sarah Larson, Douglas Sborov, Kenneth Shain, Rebecca Silbermann, Peter Voorhees, Robert Rifkin, Maria Krevvata, Mai Ngo, Sharmila Patel, Vipin Khare, Annelore Cortoos, Robin Carson, Thomas Lin, Ashraf Badros
Updated Efficacy and Safety Results of Subcutaneous Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Therapy in Newly Diagnosed Multiple Myeloma After Transplant: AURIGA Study
期刊介绍:
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.